Siga Technologies SIGA
NASDAQ SIGA
$3.09 -0.11 (-3.44%)
As of: Sep 9, 2026 · 3:59 PM EDT

Siga Technologies (SIGA) Net Cash Flow (2010 - 2025)

Siga Technologies' (SIGA) quarterly Net Cash Flow came in at -$10.5 million in Q3 2025, down 36.82% on a YoY basis from -$16.6 million in Q3 2024, and down 152.04% quarter-over-quarter from $20.2 million in Q2 2025.

Analysis

Siga Technologies (SIGA) Net Cash Flow (2010 - 2025) Analysis & Trends

Siga Technologies (SIGA) has reported Net Cash Flow for 16 consecutive years, with -$10.5 million the latest figure, recorded in Q3 2025.

  • For the quarter ending Q3 2025, Net Cash Flow fell 36.82% year-over-year to -$10.5 million; the trailing twelve-month figure through Sep 2025 stood at $72.7 million (up 158.16% YoY), and the FY2024 full-year result was $5.3 million, down 89.77% from the prior year.
  • Net Cash Flow slipped to -$10.5 million in Q3 2025 per SIGA's latest filing, from $20.2 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $79.0 million in Q4 2023 and bottomed at -$39.5 million in Q2 2023.
  • Historically, Net Cash Flow has averaged $2.8 million across 5 years, with a median of -$5.7 million in 2021.
  • The sharpest annual moves came in 2022 and 2023: Net Cash Flow tumbled 381.62% in 2022, then soared 821.16% in 2023.
  • Over 5 years, Net Cash Flow stood at $10.3 million in 2021, then sank by 206.2% to -$11.0 million in 2022, then jumped by 821.16% to $79.0 million in 2023, then retreated by 28.98% to $56.1 million in 2024, then tumbled by 118.72% to -$10.5 million in 2025.
  • According to Business Quant data, Net Cash Flow over the past three periods registered -$10.5 million, $20.2 million, and $6.9 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn -1.27 Bn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn -2.82 Bn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn 1.53 Bn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn 757.00 Mn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn -722.00 Mn
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn 918.27 Mn
7 Revolution Medicines 43.79 Bn 43.79 Bn - 374.50 Mn
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn 521.33 Mn
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn 523.50 Mn
10 Siga Technologies 220.19 Mn 65.22 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -10.51 Mn
Jun 30, 2025 20.19 Mn
Mar 31, 2025 6.87 Mn
Dec 31, 2024 56.13 Mn
Sep 30, 2024 -7.68 Mn
Jun 30, 2024 -36.92 Mn
Mar 31, 2024 -6.28 Mn
Dec 31, 2023 79.03 Mn
Sep 30, 2023 -5.10 Mn
Jun 30, 2023 -39.47 Mn
Mar 31, 2023 16.89 Mn
Dec 31, 2022 -10.96 Mn
Sep 30, 2022 -4.78 Mn
Jun 30, 2022 -38.73 Mn
Mar 31, 2022 50.12 Mn
Dec 31, 2021 10.32 Mn
Sep 30, 2021 -5.67 Mn
Jun 30, 2021 -8.04 Mn
Mar 31, 2021 -11.36 Mn
Dec 31, 2020 39.23 Mn